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In 2007, a Finnish traveler was infected in Peninsular 
Malaysia with Plasmodium knowlesi, a parasite that usually 
causes malaria in monkeys. P. knowlesi has established it-
self as the ﬁ  fth Plasmodium species that can cause human 
malaria. The disease is potentially life-threatening in hu-
mans; clinicians and laboratory personnel should become 
more aware of this pathogen in travelers.  
T
raditionally, only 4 Plasmodium species have been 
known to cause malaria in humans: P. falciparum, P. 
vivax, P. ovale, and P. malariae, although >26 Plasmodi-
um species are known to circulate among primate popula-
tions (1). Some of these species have been implicated in 
symptomatic human malaria after experimental or acciden-
tal infection (2). Only a few reports of naturally acquired 
monkey malaria in humans are currently available (1,3–9). 
The lack of data may be because light microscopy has been 
used as the sole diagnostic method and an atypical Plasmo-
dium species may have been misidentiﬁ  ed as one of the 4 
traditional Plasmodium species causing human malaria.
P. knowlesi was ﬁ  rst described in 1931 in a long-tailed 
macaque imported from Singapore to India; in 1932, P. 
knowlesi was experimentally shown to be infectious to 
humans (10). The ﬁ  rst natural infection of P. knowlesi in 
humans was reported in 1965 in a man returning to the 
United States after a visit to Peninsular Malaysia (11). Sub-
sequently, in 1971, there was a report of a presumed natu-
ral infection in a citizen of Malaysia (6). Despite extensive 
studies in Malaysia in the 1960s (2), no other reports were 
published on naturally acquired P. knowlesi infections in 
humans until 2004, when Singh et al. studied PCR-negative 
P. malariae cases in the Kapit division in Sarawak, Malay-
sia (3). A different PCR analysis showed that P. knowlesi 
caused 58% of the 208 malaria cases studied. Further cases 
reported from China (4), Thailand (5), Philippines (8), and 
Singapore (12) show that P. knowlesi infections in humans 
are not found exclusively in Malaysia. Recently, Cox-Singh 
et al. reported that P. knowlesi is widely distributed among 
inhabitants of Malaysia (7). 
The Study 
A 53-year-old Finnish man was admitted to a local 
hospital in Finland in March 2007 with fever after 4 weeks 
of travel in Peninsular Malaysia. He had not taken any an-
timalarial prophylaxis. In Malaysia, he spent 2 weeks in 
Kuala Lumpur and made a few day trips to surrounding ru-
ral areas. Thereafter, he traveled by car to the northwestern 
coast and stayed for 5 days in the jungle ≈80 km south of 
Ipoh. While in this area, he slept in a house without mos-
quito screens or nets and did not use any repellents; he did 
not report any mosquito bites. The last week of his travel 
was spent in the Langkawi Beach area where he stayed at 
a high-quality hotel. During his trip he occasionally had 
some minor abdominal problems, but these symptoms sub-
sided spontaneously after his return to Finland. High fe-
ver (38.8oC axillary temperature) occurred 3 days after his 
return to Finland but abated quickly. On the fourth day, 
the fever returned and he sought medical care at a local 
hospital. Laboratory tests showed the following results: 
C-reactive protein 2.0 mg/dL (normal range <1.0 mg/dL), 
hemoglobin 15.2 g/dL (normal range 13.4–16.7 g/dL), leu-
kocyte count 2.6 × 109/L (normal range 3.4–8.2 × 109/L), 
and thrombocytes 143 × 109/L (normal range 150–360 × 
109/L). Blood smear was positive for Plasmodium organ-
isms, and the causative agent was identiﬁ  ed as P. falci-
parum with levels of parasitemia <1.0%. The patient was 
admitted to the hospital and given intravenous (IV) quinine 
dihydrochloride and oral doxycycline.
On day 2 of the patient’s hospital stay, fever returned 
and he was transferred to the Helsinki University Central 
Hospital (Department of Infectious Diseases at Aurora 
Hospital). Blood smears obtained there showed Plasmodi-
um parasites that were considered atypical, and the labora-
tory reported suspicion of a co-infection (P. falciparum and 
P. malariae) (Figure). The IV quinine dihydrochloride was 
replaced with oral quinine hydrochloride, and doxycycline 
was continued. During treatment, the patient experienced 
an attack of hypoglycemia (electrocardiogram and blood 
pressure was normal during this attack), transient mild vi-
sual and hearing loss, and transient lymphopenia (a low 
of 0.46 × 109/L). He received quinine hydrochloride and 
doxycycline for a total of 10 days. 
Because identiﬁ  cation of the Plasmodium species was 
difﬁ  cult, a blood sample was drawn for PCR analysis on 
day 2 of hospitalization. First, a nested PCR was performed 
according to a standard protocol with rOva1 and rPLU2 
primers (template DNA puriﬁ  ed in Basel from 200 μL of 
erythrocytes by QIAamp DNA Mini Blood Kit (QIAGEN, 
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Helsinki, Finland) (13,14), but the reaction did not yield 
any ampliﬁ  cation product. Nested PCR was repeated with 
an alternative primer pair (rPLU6 and rPLU2) (14) derived 
from a conserved region of the 18S rRNA marker gene, and 
an amplicon was obtained. Failure of PCR ampliﬁ  cation has 
been reported for some P. ovale isolates (15); therefore, a 
P. ovale infection was suspected, and the patient was given 
primaquine phosphate for 14 days as an outpatient to eradi-
cate possible liver hypnozoites. The PCR product was sub-
jected to direct nucleotide sequencing (GenBank accession 
no. FJ009511) and found to be identical to 2 P. knowlesi se-
quences previously submitted to GenBank, 1 human isolate 
from Malaysian Borneo (AY327556) and a Macaca mu-
latta isolate from Columbia (U72542). Six other published 
P. knowlesi sequences differ from our sequence only by 1 
nucleotide (99% identity). In contrast, a number of differ-
ences were seen between our sequence and the P. ovale 
sequences (15). The sequence from our case showed only 
50% identity to the ova1e primer; therefore, we concluded 
that our patient was infected with P. knowlesi. During the 
12-month follow-up period, the patient showed no signs of 
relapse. 
Conclusions
We suggest that P. knowlesi infection should be con-
sidered in malaria patients who have a history of a travel to 
forested areas in Southeast Asia, especially if P. malariae 
malaria is diagnosed or atypical plasmodia are seen with 
microscopy. The asexual stages of various species of P. 
knowlesi can easily be misidentiﬁ  ed as P. malariae in light 
microscopic examination (Figure) (3,7,10). Because most 
laboratories diagnose malaria by light microscope exami-
nation only, numerous cases of P. knowlesi malaria may 
have been misdiagnosed as ordinary P. malariae malaria; 
monkey malaria may be more widespread among humans 
than was previously thought. As the disease is potentially 
dangerous, a proper identiﬁ  cation of the malaria species is 
crucial. If PCR assays for malaria detection are used, PCR 
primers speciﬁ  c for P. knowlesi (3) should be included to 
provide valuable diagnostic information. 
P. knowlesi has established itself as the ﬁ  fth species of 
Plasmodium that causes human malaria (3,7,12). Because 
the disease is potentially life-threatening in humans, labora-
tory clinicians and physicians (especially those taking care 
of travelers) should become more aware of this disease; it is 
easily misdiagnosed as a less severe form of malaria.   
Acknowledgments
We thank the patient for allowing us to publish his case, Heli 
Siikamäki for helpful discussions, and personnel of the Unit of 
Parasitology, Helsinki University Central Hospital Laboratory, 
for recognizing the atypical nature of Plasmodium parasites in the 
patient’s thin blood smears. 
  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 14, No. 9, September 2008  1435 
Figure. Microscopic ﬁ  ndings in the thin blood smears of a patient 
with  Plasmodium knowlesi malaria. Early ring forms are shown 
in the ﬁ   rst row, later trophozoites in the second and third rows, 
trophozoites resembling band forms in the fourth row, and putative 
early gametocytes or schizonts in the ﬁ  fth row. Size of the infected 
erythrocytes is normal. Antimalarial medications, given 8 hours 
before the blood shown in the smear was drawn, could have 
affected morphology. (Original magniﬁ  cation ×1,000.)The research of T.S.J. is ﬁ  nancially supported by the Acade-
my of Finland (projects 201506 and 202529), the Helsinki Univer-
sity Central Hospital Funds, and the Sigrid Jusélius Foundation; 
the work of A.K. is supported by the Finnish Medical Foundation 
and the special Finnish governmental subsidy for health sciences 
research.
Dr Kantele is an infectious diseases specialist in the Division 
of Infectious Diseases, Helsinki University Central Hospital. She 
is also a scientist in the Department of Microbiology and Immu-
nology, Helsinki University. Her research has focused on immune 
responses to infections and vaccines, and recently she has become 
interested in travel medicine and tropical diseases. 
References
  1.   Rich SM, Ayala FJ. Progress in malaria research: the case for phylo-
genetics. Adv Parasitol. 2003;54:255–80. DOI: 10.1016/S0065-308-
X(03)54005-2
  2.   Garnham PCC. Malaria parasites and other haemosporidia. Oxford 
(UK): Blackwell Scientiﬁ  c Publications; 1966.
  3.   Singh B, Kim Sung L, Matusop A, Radhakrishnan A, Shamsul SS, 
Cox-Singh J, et al. A large focus of naturally acquired Plasmodium 
knowlesi infections in human beings. Lancet. 2004;363:1017–24. 
DOI: 10.1016/S0140-6736(04)15836-4
  4.   Zhu HM, Li J, Zheng H. Human natural infection of Plasmodium 
knowlesi [in Chinese]. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng 
Chong Bing Za Zhi. 2006;24:70–1.
  5.   Jongwutiwes S, Putaporntip C, Iwasaki T, Sata T, Kanbara H. Natu-
rally acquired Plasmodium knowlesi malaria in human, Thailand. 
Emerg Infect Dis. 2004;10:2211–3.
  6.   Fong YL, Cadigan FC, Coatney GR. A presumptive case of naturally 
occurring Plasmodium knowlesi malaria in man in Malaysia. Trans 
R Soc Trop Med Hyg. 1971;65:839–40. DOI: 10.1016/0035-9203
(71)90103-9
  7.   Cox-Singh J, Davis TM, Lee KS, Shamsul SS, Matusop A, Ratnam 
S, et al. Plasmodium knowlesi malaria in humans is widely distribut-
ed and potentially life threatening. Clin Infect Dis. 2008;46:165–71. 
DOI: 10.1086/524888
  8.   Luchavez J, Espino F, Curameng P, Espina R, Bell D, Chiodini P, 
et al. Human infections with Plasmodium knowlesi, the Philippines. 
Emerg Infect Dis. 2008;14:811–3.
  9.   Ng OT, Ooi EE, Lee CC, Lee PJ, Ng LC, Pei SW, et al. Naturally 
acquired human Plasmodium knowlesi infection, Singapore. Emerg 
Infect Dis. 2008;14:814–6.
10.   Knowles R, Das Gupta BM. A study of monkey malaria and its ex-
perimental transmission to man (preliminary report). Ind Med Gaz. 
1932;67:301–20.
11.   Chin W, Contacos PG, Coatney GR, Kimball HR. A naturally ac-
quired quotidian-type malaria in man transferable to monkeys. Sci-
ence. 1965;149:865. DOI: 10.1126/science.149.3686.865
12.    Fleck F. Monkey malaria could represent a new human strain. 
Bull World Health Organ 2004;82:392–3. DOI: 10.1590/S0042-
96862004000500017  
13.   Snounou G, Singh B. Nested PCR analysis of Plasmodium parasites. 
Methods Mol Med. 2002;72:189–203.
14.  Snounou G, Viriyakosol S, Zhu XP, Jarra W, Pinheiro L, do Rosario 
VE, et al. High sensitivity of detection of human malaria parasites by 
the use of nested polymerase chain reaction. Mol Biochem Parasitol. 
1993;61:315–20. DOI: 10.1016/0166-6851(93)90077-B
15.   Win TT, Jalloh A, Tantular IS, Tsuboi T, Ferreira MU, Kimura M, et 
al. Molecular analysis of Plasmodium ovale variants. Emerg Infect 
Dis. 2004;10:1235–40.
Address for correspondence: Anu Kantele, Helsinki University Central 
Hospital, Department of Medicine, Division of Infectious Diseases, 
Aurora Hospital, Building 5, 3rd Floor, Post Ofﬁ  ce Box 348, FIN-00029 
HUS, Helsinki, Finland; email: anu.kantele@hus.ﬁ   
DISPATCHES
1436  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 14, No. 9, September 2008
Use of trade names is for identiﬁ  cation only and does not imply 
endorsement by the Public Health Service or by the U.S. 
Department of Health and Human Services.
Search 
past Issues